Headache
DOI:
https://doi.org/10.47924/neurotarget2015224Keywords:
headache, migraine, tension headaches, diagnostic, treatment, evidence, recomendationAbstract
Cephalalgia is a symptom and sometimes a highly preva- lent disease in medicine, often getting the wrong diagnosis or inadequate treatment. To receive a particular headache diagnosis patient must, in many cases, experience a minimum number of attacks. For this reason it is important a good initial assessment of patients to rule out a secondary headache and refer to a specialist timely. However primary headaches are the most common cause of craniofacial pain, especially migraine and tension headaches, which currently have both pharmacological and non-pharmacological evidence for good management.
Metrics
References
Morgenstern LB, Huber JC, Luna-Gonzales H, Saldin KR, Grotta JC, Shaw SG, et al. Headache in the emergency department. Headache. 2001;41(6):537-41.
Steiner TJ. Lifting The Burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain. 2005;6(5):373-7.
Headache Classification Committee of the International Headache Society (IHS).The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
Comité de Clasificación de la Cefalea de la International Headache Society (IHS). III Edición de la Clasificación Internacional de las Cefa- leas, versión beta (marzo de 2013) [Internet]. Londres, Reino Unido: Sage Publications, International Headache Society; 2013 [citado 28 jul 2015]. Disponible en: http://www.sen.es/pdf/2014/cic3_beta.pdf.
Levin M. The International Classification of Headache Disorders, 3rd Edition (ICDH III) - Changes and Challenges. Headache 2013;53(8):1383-95.
Evans RW, Rozen TD, Mechter L. Neuroimaging and other diagnostic testing in headache. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s headache and other head pain. 8th ed. New York: Oxford University Press; 2008. p. 63-93.
Loder E, Weizenbaum E, Frishberg B, Silberstein S; American Headache Society Choosing Wisely Task Force. Choosing wisely in headache medicine: the American Headache Society’s list of five things physicians and patients should question. Headache. 2013;53(10):1651-9.
Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(Suppl 1):S15-22.
Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011;51(3):469-83.
Andrasik F. Biofeedback in headache: an overview of approaches and evidence. Cleve Clin J Med. 2010;77 Suppl 3:S72-6
Fritsche G, Kröner-Herwig B, Kropp P, Niederberger U, Haag G. [Psychological therapy of migraine: systematic review]. [Article in German] Schmerz. 2013;27(3):263-74.
Da Silva AN. Acupuncture for migraine prevention. Headache. 2015;55(3):470-3.
Loreto M. Cefaleas, evaluación y manejo inicial. Rev Med Clin Condes. 2014;25(4):651-7.
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al; European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968-81.
Minen MT, Tanev K, Friedman BW. Evaluation and treatment of migraine in the emergency department: a review. Headache. 2014;54(7):1131-45.
Silberstein SD. Treatment recommendations for migraine. Nat Clin Pract Neurol. 2008;4(9):482-9.
Rizzoli PB. Acute and preventive treatment of migraine. Continuum (Minneap Minn). 2012;18(4):764-82.
Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society eviden- ce assessment of migraine pharmacotherapies. Headache. 2015;55(1):3-20.
Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Headache. 2012;52(3):467-82.
Levin M. Opioids in headache. Headache. 2014;54(1):12-21.
Tepper SJ. Opioids should not be used in migraine. Headache. 2012;52 Suppl 1:30-4.
Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008041.
Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium. Headache. 2012;52(1):114-28.
Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60(6):1259-87.
Roberto G, Raschi E, Piccinni C, Conti V, Vignatelli L, D’Alessandro R, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia. 2015;35(2):118-31.
Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, et al. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology. 2008;71(2):114-21.
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Qua- lity Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337-45.
Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and compa- rison with other recentclinical practice guidelines. Headache. 2012;52(6):930-45.
Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.
Lipton RB, Silberstein SD. Episodic and chronic migraine heada- che: breaking down barriers to optimal treatment and prevention. Headache. 2015;55 Suppl 2:103-22; quiz 123-6.
Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.
Topiramate reduces headache days in chronic migraine: a ran- domized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814-23.
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610.
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013 Jun 24;6:CD010609.
Torres y Gutiérrez Rubio A. Efecto analgésico de las vitaminas del complejo B, a 50 años de la primera combinación fija de tiamina, piridoxina y cianocobalamina. Med Int Mex. 2012;28(5):473-82.
Dach F, Éckeli ÁL, Ferreira Kdos S, Speciali JG. Nerve block for the treatment of headaches and cranial neuralgias - a practical approach. Headache. 2015;55 Suppl 1:59-71.
Broggi G, Messina G, Marras C, Dones I, Franzini A. Neuromo- dulation for refractory headaches. Neurol Sci. 2010;31 Suppl 1:S87-92.
Pascual J. Migraña crónica: tratamiento. Rev Neurol. 2012; 54(Suppl 2):S31-8.
Giacomozzi AR, Vindas AP, da Silva Junior AA, Bordini CA, Buo- nanotte CF, Roesler CA, et al. Consenso latinoamericano para las directrices de tratamiento de la migraña crónica. Headache Med. 2012;3(4):162-72.
Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al; Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47(2):170-80.
Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al; PREEMPT 2 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migrai- ne: results from the double-blind, randomized, placebo- controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804-14.
Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Hea- dache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003;61(12):1753-9.
Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol. 2005;20(3):243-9.
Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J; EFNS. EFNS guideline on the treatment of tension- type headache - report of an EFNS task force. Eur J Neurol. 2010;17(11):1318-25.
Brennum J, Brinck T, Schriver L, Wanscher B, Soelberg Sørensen P, Tfelt-Hansen P, et al. Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol. 1996;3(1):23-8.
Finkel AG. Proceedings: Botulinum toxin and the treatment of headache: A clinical review.Toxicon. 2015. doi:10.1016/j.toxicon.2015.09.008 [Epub ahead of print]
Lipton RB, Silberstein SD, Sager JB, Bigal ME, Goadsby PJ. Why hedache treatment fails. Neurology 2003; 60(7):1064-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 María Loreto Cid-Jeffs
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
